Becton Dickinson and Co (BDX.N)
16 Feb 2018
Fri, Feb 16 2018
* BECTON DICKINSON AND CO FILES FOR OFFERING EUR 300 MILLION AGGREGATE PRINCIPAL AMOUNT OF ADDITIONAL 0.368% NOTES DUE 2019 - SEC FILING
* FDA APPROVES NEW HPV TEST THAT DETECTS AND IDENTIFIES HPV GENOTYPES THAT PUT WOMEN AT HIGH RISK FOR CERVICAL CANCER Source text for Eikon: Further company coverage:
* BD ANNOUNCES RESULTS FOR 2018 FIRST FISCAL QUARTER; PROVIDES FISCAL 2018 GUIDANCE UPDATED FOR INCLUSION OF BARD
* BD STATEMENT ON FDA WARNING LETTER FOR PREANALYTICAL SYSTEMS BUSINESS UNIT
* FDA WARNS BECTON DICKINSON & COMPANY OF SIGNIFICANT VIOLATIONS OF THE LAW AS PART OF ONGOING INVESTIGATION INTO LEAD TESTING ISSUES
BEIJING China's commerce ministry said on Thursday that it has conditionally approved the takeover by U.S. medical equipment supplier Becton Dickinson of its U.S. peer C R Bard, paving the way for the $24 billion deal to close.
* Becton had said China approval was last hurdle for deal to close
BEIJING China's commerce ministry said on Thursday that it has conditionally approved a merger between U.S. medical equipment supplier Becton Dickinson and its U.S. peer C R Bard .
BEIJING, Dec 28 China's commerce ministry said on Thursday that it has conditionally approved a merger between U.S. medical equipment supplier Becton Dickinson and its U.S. peer C R Bard.
WASHINGTON U.S. medical equipment supplier Becton Dickinson and C R Bard have agreed to divest two product lines to satisfy U.S. Federal Trade Commission concerns their proposed $24 billion merger would negatively affect competition.
- Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q4 2017 Update
- Becton, Dickinson & Co. (BDX) Q1 2018 Results - Earnings Call Transcript
- Becton, Dickinson and Company 2018 Q1 - Results - Earnings Call Slides
- Dividend Aristocrat Performance: January 2018
- The Performance Of Every Dividend Aristocrat During The Great Recession
- A Want-To-Buy List For My 91 Stock Portfolio